Pharmaceuticals Companies
Explore Pharmaceutical companies developing, manufacturing, and marketing medicines, therapeutics, vaccines, and healthcare products.
Sorted by Revenue (Highest to Lowest). Click any column header to re-sort.
| S.No. | Company Profile | Revenue | Operating Profit | Operating Cash Flow | ROCE | Cash ROCE | Action |
|---|---|---|---|---|---|---|---|
| 1. | Novo Nordisk A/S (NYSE: NVO) | DKK 234.55 B | — | DKK 4.20 B | — | — | View Data |
| 2. | Bristol-Myers Squibb Company (NYSE: BMY) | $48.19 B (▼ 0.2%) | $9.33 B (▲ 211.3%) | $14.16 B (▼ 6.8%) | 38.12 % (▲ 9272 bps) | 76.49 % (▼ 1620 bps) | View Data |
| 3. | Pfizer Inc. (NYSE: PFE) | $62.58 B (▼ 1.6%) | $7.79 B (▼ 3.3%) | $11.70 B (▼ 8.2%) | 8.96 % (▼ 12 bps) | 13.49 % (▼ 91 bps) | View Data |
| 4. | Gilead Sciences, Inc. (NASDAQ: GILD) | $29.44 B (▲ 2.4%) | $10.02 B (▲ 503.0%) | $10.02 B (▼ 7.5%) | 37.62 % (▲ 3513 bps) | 44.30 % (▼ 1196 bps) | View Data |
| 5. | Roche Bobois SA (EURONEXT: RBO) | €402.50 M (▼ 2.8%) | — | — | 9.60 % | — | View Data |
| 6. | Clinuvel Pharmaceuticals Limited (NASDAQ: CUVL) | $64.32 M (▲ 5.2%) | $27.92 M (▲ 5.3%) | $12.91 M (▼ 52.7%) | 12.29 % (▼ 246 bps) | 6.84 % (▼ 1057 bps) | View Data |
| 7. | Abbott Laboratories (NYSE: ABT / NYSE Texas: ABT) | $44.33 B (▲ 5.7%) | $8.05 B (▲ 18.0%) | $9.57 B (▲ 11.8%) | 12.36 % (▼ 1562 bps) | 18.13 % (▲ 26 bps) | View Data |
| 8. | Johnson & Johnson (NYSE: JNJ) | $94.19 B (▲ 6.0%) | $32.58 B (▲ 95.2%) | $24.53 B (▲ 1.1%) | 32.87 % (▲ 1320 bps) | 30.08 % (▼ 386 bps) | View Data |
| 9. | AbbVie Inc. (NYSE: ABBV) | $61.16 B (▲ 8.6%) | $15.07 B (▲ 65.0%) | — | 0.46x (▲ 0.04 pts) | 7.62x | View Data |
| 10. | Eli Lilly and Company (NYSE: LLY) | $65.18 B (▲ 44.7%) | $25.73 B (▲ 102.9%) | $16.81 B (▲ 90.7%) | 77.78 % (▲ 358 bps) | 63.36 % (▲ 158 bps) | View Data |
| 11. | Merck & Co., Inc. (NYSE: MRK) | — | — | — | — | — | View Data |